NEXENTIS TECHNOLOGIES INC. Proceeds from Loans
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Proceeds from Loans of $125.00 thousand for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromLoans · last filed 2020-11-12
- NEXENTIS TECHNOLOGIES INC. proceeds from loans for fiscal 2019 was $379.00K.
| Period end | Proceeds from Loans 9 month | Proceeds from Loans 12 month |
|---|---|---|
| 2020-09-30 | $125.00K 10-Q · filed 2020-11-12 | |
| 2019-12-31 | $379.00K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |